相关实验视频
Updated: May 30, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
瑞典新生儿高血糖症的管理-一项调查研究
Ludvig Henriksson Frithiof1, Magnus Domellöf1, Itay Nilsson Zamir1
1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
Acta paediatrica (Oslo, Norway : 1992)
|January 31, 2025
概括
新生儿高血糖症的管理在瑞典新生儿病房之间有很大差异,这凸显了对标准化治疗指南的需求. 这项研究揭示了在早产婴儿中定义和治疗高血糖的不一致性.
科学领域:
- 新生儿医学 新生儿医学
- 内分泌学 在内分泌学.
- 临床实践研究 临床实践研究
背景情况:
- 新生儿高血糖症与不良结果有关,包括死亡率和神经发育问题.
- 有效的管理策略对于改善婴儿健康结果至关重要.
- 缺乏标准化的指导方针可能会导致不一致的护理.
研究的目的:
- 描述当前的临床实践,用于管理新生儿高血糖症在瑞典新生儿单位.
- 确定新生儿高血糖症的定义,治疗门和干预措施的变化.
主要方法:
- 在27个照顾早产婴儿的瑞典新生儿单位 (<32周妊娠年龄) 分发了一项数字调查.
- 来自21个不同单位的68名临床医生收集了数据.
- 调查重点关注高血糖的定义,干预的葡萄糖度值,以及胰岛素的使用.
主要成果:
- 只有32%的临床医生报告说,他们有新生儿高血糖症的局部治疗指南.
- 在高血糖的定义中存在显著的差异,值从8.0到超过12.0mmol/L.
- 开始治疗静脉注射降糖和胰岛素的情况有很大差异,一些单位在胰岛素治疗期间报告了低血糖问题.
结论:
- 新生儿高血糖管理的临床实践在瑞典新生儿病房内和新生儿病房之间存在很大差异.
- 需要基于证据的临床指导方针来规范护理.
- 随机对照试验对于指导方针的制定和改善婴儿结果至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Pathophysiology of Diabetes
852
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K

